<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35349909</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1557-8615</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>69</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of critical care</Title>
          <ISOAbbreviation>J Crit Care</ISOAbbreviation>
        </Journal>
        <ArticleTitle>High flow nasal cannula improves breathing efficiency and ventilatory ratio in COPD patients recovering from an exacerbation.</ArticleTitle>
        <Pagination>
          <StartPage>154023</StartPage>
          <MedlinePgn>154023</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2022.154023</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0883-9441(22)00051-X</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND AND STUDY PURPOSE" NlmCategory="OBJECTIVE">High flow nasal cannula (HFNC) may improve CO<sub>2</sub> elimination by washing out CO<sub>2</sub> from the upper airways. This study aimed at assessing the effect of HFNC on minute ventilation and ventilatory ratio (VR), a surrogate of dead space, in patients hospitalized for acute hypercapnic COPD exacerbation.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Physiological study comparing HFNC at 40 L/min to low flow oxygen. Variations of tidal volume (VT) and minute ventilation between the two treatments were estimated from chest plethysmography. Respiratory rate (RR) and arterial blood gases were measured. Variations in VR were calculated. Data were compared using Wilcoxon tests.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Recordings performed in 10 patients. Minute ventilation was reduced with HFNC by -16.2 [-30.9-0.4] % (p = 0.049). VT was not different but RR was lower during HFNC. PaCO<sub>2</sub> was lower with HFNC compared to standard oxygen: 48.7 [46.4-58.1] vs 50.7 [48.4-57.5] mmHg (p = 0.020). VR decreased by -18.0 [-34.7 - -4.0] % (p = 0.020) with HFNC.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In patients recovering from acute COPD exacerbation, the use of HFNC reduced RR, minute ventilation, PaCO<sub>2</sub> and VR compared to standard oxygen. These changes are consistent with a decrease in physiologic dead space with HFNC.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Piquilloud</LastName>
            <ForeName>Lise</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Médecine Intensive - Réanimation, CHU d'Angers, Vent'Lab, Université d'Angers, 4 Rue Larrey, 49100 Angers, France; Adult Intensive Care Unit, University Hospital and University of Lausanne, 46 Route du Bugnon, 1011 Lausanne, Switzerland. Electronic address: lise.piquilloud@chuv.ch.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Olivier</LastName>
            <ForeName>Pierre-Yves</ForeName>
            <Initials>PY</Initials>
            <AffiliationInfo>
              <Affiliation>Médecine Intensive - Réanimation, CHU d'Angers, Vent'Lab, Université d'Angers, 4 Rue Larrey, 49100 Angers, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Richard</LastName>
            <ForeName>Jean-Christophe</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Médecine Intensive - Réanimation, CHU d'Angers, Vent'Lab, Université d'Angers, 4 Rue Larrey, 49100 Angers, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thepot-Seegers</LastName>
            <ForeName>Valérie</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Biometric unit, ICO Integrated Center for Oncology, 15, Rue André Boquel, 49055 Angers, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brochard</LastName>
            <ForeName>Laurent</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 204 Victoria Street, Toronto, Ontario M5B 1T8, Canada; Interdepartmental Division of Critical Care Medicine, University of Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mercat</LastName>
            <ForeName>Alain</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Médecine Intensive - Réanimation, CHU d'Angers, Vent'Lab, Université d'Angers, 4 Rue Larrey, 49100 Angers, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Beloncle</LastName>
            <ForeName>François</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Médecine Intensive - Réanimation, CHU d'Angers, Vent'Lab, Université d'Angers, 4 Rue Larrey, 49100 Angers, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>26</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Crit Care</MedlineTA>
        <NlmUniqueID>8610642</NlmUniqueID>
        <ISSNLinking>0883-9441</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>142M471B3J</RegistryNumber>
          <NameOfSubstance UI="D002245">Carbon Dioxide</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>S88TT14065</RegistryNumber>
          <NameOfSubstance UI="D010100">Oxygen</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000072601" MajorTopicYN="N">Cannula</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002245" MajorTopicYN="N">Carbon Dioxide</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063087" MajorTopicYN="Y">Noninvasive Ventilation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010102" MajorTopicYN="N">Oxygen Inhalation Therapy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D029424" MajorTopicYN="Y">Pulmonary Disease, Chronic Obstructive</DescriptorName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>Declaration of Competing Interest Dr. Piquilloud reports conference fees from Getinge group and Hamilton Medical, research support from Draeger and personal fees from Löwenstein Medical, outside this work. Dr. Olivier reports personal fees from Air Liquid Medical Systems, outside this work. Prof Richard reports part-time salary for research activities from Air Liquide Medical Systems and Vygon and grants from Creative Air Liquide, outside this work. Prof Brochard reports receiving grants from Medtronic Covidien and grants and equipment for research from Fisher Paykel, Philips, Sentec, and Air Liquide outside this work. Prof Mercat reports personal fees from Faron Pharmaceuticals, Air Liquid Medical Systems, Pfizer, Resmed and Draeger and grants and personal fees from Fisher and Paykel and Covidien, outside this work. Dr. Beloncle reports personal fees from Löwenstein Medical and research support from Covidien, GE Healthcare and Getinge Group, outside this work. Dr. Thepot-Seegers has no conflicts of interest to declare.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>29</Day>
          <Hour>20</Hour>
          <Minute>10</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35349909</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jcrc.2022.154023</ArticleId>
        <ArticleId IdType="pii">S0883-9441(22)00051-X</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
